Annual Meeting

Phthalate alternative may harm brain development and health

Acetyl tributyl citrate, a leading phthalate alternative, found to disrupt neuron-like cells
Anne Frances Johnson
March 27, 2023

Growing concerns over the potential health effects of exposure to phthalates, a component of many plastics and also known as a plasticizer, have led to a search for safer alternatives. In a new study conducted in cell cultures, researchers found that the chemical acetyl tributyl citrate (ATBC) might not be the best replacement because it appears to interfere with the growth and maintenance of neurons.

“In the past, industries have promptly shifted away from the usage of toxic chemicals only to produce an equally toxic chemical, so this is something we are actively trying to avoid repeating,” said Kyle Sease, a graduate student at Central Washington University in Ellensburg, Washington. “Our study suggests that ATBC, but not other non-phthalate alternatives, could interfere with cells that maintain brain health. We think this finding warrants further testing of ATBC at different doses, in different settings and in whole organism models.”

Sease will present the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, March 25–28 in Seattle.

Phthalates are used in hundreds of products, often to enhance durability or allow materials to bend and stretch. Studies have shown that phthalate exposure can affect the reproductive system and early development in a range of animals, although the health impacts in humans are not clear. ATBC has emerged as a leading phthalate alternative as companies seek to shift away from phthalates and is currently used in a variety of materials and products, including food and food packaging.

For the study, researchers grew cultures of neuroblastoma cells, which, in terms of growth and division, behave similarly to the glial cells that support and protect neurons in the brain. They then used molecular methods to study how ATBC and other chemicals affect genes and processes involved in cellular division. They found that neuroblastoma cells exposed to ATBC increased their expression of two genes associated with cellular stress (known as Nrf2 and p53) and also increased their production of an enzyme associated with cellular senescence (B-galactosidase), which can cause cells to stop growing and dividing.

The findings suggest that ATBC could interfere with the ability for glial cells to regenerate, which can reduce their ability to protect neural cells and lead to neurodegeneration and accelerated aging. It is also possible that ATBC exposure during early development — when neurons are actively growing and dividing — could affect neurons directly and interfere with brain development, the researchers said. Since neurons do not typically regrow once damaged, any effects on the brain likely would be permanent. 

Two other phthalate alternatives, bis (2-ethylhexyl)-1, 4-benzenedicarboxylate (GPO) and dioctyl adipate (DOA), did not show the same effects as ATBC. “We found that two other plasticizers did not appear to affect cell division in these cells, so further understanding the different effects of different plasticizers will allow us to understand better how to make safe ones,” Sease said.

Kyle Sease will present this research from 4:30–6:30 p.m. PDT on Monday, March 27, in Exhibit Hall 4AB of the Seattle Convention Center (Poster Board No. 141) (abstract). Contact the media team for more information or to obtain a free press pass to attend the meeting.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at Creative Science Writing based in Chapel Hill, North Carolina. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.